Yokukansan inhibits neuronal death during ER stress by regulating the unfolded protein response.
<h4>Background</h4>Recently, several studies have reported Yokukansan (Tsumura TJ-54), a traditional Japanese medicine, as a potential new drug for the treatment of Alzheimer's disease (AD). Endoplasmic reticulum (ER) stress is known to play an important role in the pathogenesis of...
Guardado en:
Autores principales: | Toru Hiratsuka, Shinsuke Matsuzaki, Shingo Miyata, Mitsuhiro Kinoshita, Kazuaki Kakehi, Shinji Nishida, Taiichi Katayama, Masaya Tohyama |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9199ae2f7a49460da6d55aded088de7d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats
por: Kanada Y, et al.
Publicado: (2018) -
Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion
por: Katahira H, et al.
Publicado: (2017) -
Yokukansan and its ingredients as possible treatment options for schizophrenia
por: Yu CH, et al.
Publicado: (2014) -
Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function
por: Takeyoshi K, et al.
Publicado: (2016) -
Direct association of unfolded proteins with mammalian ER stress sensor, IRE1β.
por: Daisuke Oikawa, et al.
Publicado: (2012)